18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer.
Brendan T HeidenGuoan ChenMatthew HermannRichard K J BrownMark B OrringerJules LinAndrew C ChangPhilip W CarrottWilliam R LynchLili ZhaoDavid G BeerRishindra M ReddyPublished in: PloS one (2018)
PET-intensity is associated with a variety of oncogenic alterations in operable NSCLC. Adjuvant targeting of these pathways may improve survival among patients with PET-intense tumors.